Patents by Inventor Janos Szolcsanyi

Janos Szolcsanyi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Agents for treating neurogenic inflammation and neuropathic hyperalgesia related disorders
    Patent number: 10344032
    Abstract: The present invention relates to 4-phenetylamino-7H-pyrrolo[2,3-d]pyrimidine derivatives of the and solvates, hydrates and pharmaceutically acceptable salts thereof, processes for manufacturing of them, the use of them, as well as pharmaceutical compositions containing at least one of them as pharmaceutically active agent(s) together with pharmaceutically acceptable carrier, excipient and/or diluents, especially for the prevention and/or treatment of acute neurogenic inflammation and/or neuropathic hyperalgesia. Said 4-phenetylamino-7H-pyrrolo[2,3-d]pyrimidine compounds have been identified as new drug candidates for the prevention and/or treatment of acute neurogenic inflammation and/or neuropathic hyperalgesia.
    Type: Grant
    Filed: October 28, 2014
    Date of Patent: July 9, 2019
    Assignee: Pécsi Tudományegyetem
    Inventors: János Szolcsányi, Erika Pintér, Zsuzsanna Helyes, Éva Szöke, Frigyes Wáczek, László Örfi, György Kéri, Tamás Szüts
  • NEW AGENTS FOR TREATING NEUROGENIC INFLAMMATION AND NEUROPATHIC HYPERALGESIA RELATED DISORDERS
    Publication number: 20170260187
    Abstract: The present invention relates to 4-phenetylamino-7H-pyrrolo[2,3-d]pyrimidine derivatives of the and solvates, hydrates and pharmaceutically acceptable salts thereof, processes for manufacturing of them, the use of them, as well as pharmaceutical N compositions containing at least one of them as pharmaceutically active agent(s) together with pharmaceutically acceptable carrier, excipient and/or diluents, especially for the prevention and/or treatment of acute neurogenic inflammation and/or neuropathic hyperalgesia. Said 4-phenetylamino-7H-pyrrolo[2,3-d]pyrimidine compounds have been identified as new drug candidates for the prevention and/or treatment of acute neurogenic inflammation and/or neuropathic hyperalgesia.
    Type: Application
    Filed: October 28, 2014
    Publication date: September 14, 2017
    Inventors: János SZOLCSÁNYI, Erika PINTÉR, Zsuzsanna HELYES, Éva SZÖKE, Frigyes WÁCZEK, László ÖRFI, György KÉRI, Tamás SZÜTS
  • 7H-Pyrrolo[2,3-D]Pyrimidine Derivatives, As Well As Their Therapeutically Acceptable Salts, Pharmaceutical Preparations Containing Them And Process For Production The Active Agent
    Publication number: 20080214583
    Abstract: The invention relates to new 7H-pyrrolo[2,3-d]pyrimidine derivatives, as well as their therapeutically acceptable salts, pharmaceutical preparations containing them and process for producing the active agent. The pharmaceutical preparation is adventageously antiphlogistic and analgetic one, a preparation reducing neuropathic hyperalgesia and rheumatic arthritis, a preparation for hindering destruction of bones chondrus, being applicable for treatment of other diseases, which may be connected with other inflammatory processes e.g. asthma, eczema or psoriasis.
    Type: Application
    Filed: April 25, 2005
    Publication date: September 4, 2008
    Inventors: Janos Szolcsanyi, Laszlo Orfi, Gyorgy Keri, Frigyes Waczek, Erika Pinter, Zsusanna Helyes, Tamas Szuts, Jozsef Nemeth
  • Process for the preparation of pharmaceutical compositions possessing neurogenic or non-neurogenic anti-inflammatory as well as analgetic effects
    Patent number: 6689813
    Abstract: The invention relates to the use of peptide amides of formula (I) and phenylamino-oxoacetic acid derivatives of formula (II) as well as the salts of the above compounds as active substances for the preparation of pharmaceutical compositions possessing neurogenic and non-neurogenic antiinflammatory as well as analgetic effects.
    Type: Grant
    Filed: January 5, 2001
    Date of Patent: February 10, 2004
    Assignee: Biostatin Gyogyszerkutato-Fejleszto kft.
    Inventors: György Kéri, János Szolcsányi, Erika Pintér, Zsuzsanna Helyes, Judit Érchegyi, Anikó Horváth, Judith Horváth, István Teplán, László Õrfi
  • Penta-or tetrapeptide binding to somatostatin receptors and the use of the same
    Publication number: 20030114362
    Abstract: The subject matter of the present invention is a cyclic or linear tetra- or pentapeptide binding to somatostatin receptors. The compounds of the invention are characterised in that they contain the radical of an amino carboxylic acid bearing a five-membered ring in the peptide backbone which may optionally contain O, S, Se, N, or P. These compounds are easy to prepare and display increased stability against peptidases.
    Type: Application
    Filed: June 7, 2002
    Publication date: June 19, 2003
    Applicant: Novaspin Biotech GmbH
    Inventors: Sibylle Gruner, Gyorgy Keri, Horst Kessler, Erika Pinter, Richard Schwab, Janos Szolcsanyi, Aniko Venetianer
  • Process for the preparation of pharmaceutical compositions possessing neurogenic or non-neurogenic anti-inflammatory as well as analgetic effects
    Publication number: 20010009899
    Abstract: The invention relates to the use of peptide amides of formula (I) 1
    Type: Application
    Filed: January 5, 2001
    Publication date: July 26, 2001
    Inventors: Gyorgy Keri, Janos Szolcsanyi, Erika Pinter, Zsuzsanna Helyes, Judit Erchegyi, Aniko Horvath, Judit Horvath, Istvan Teplan, Laszlo Orfi